Geode Capital Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SM
Geode Capital Management's MTRI Position: Q3 2022 in Review
Geode Capital Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2022, closing a stake of 3 shares — an estimated $6K sold.
Geode Capital Management first reported a position in MTRI in Q1 2022 and held it in 2 quarters. The position peaked at $13K in Q1 2022. 7 funds tracked by Wall St. Rank hold MTRI as of Q3 2022.
- Geode Capital Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Geode Capital Management sold 3 Mentari Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $6K.
- Geode Capital Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
- Geode Capital Management's Mentari Therapeutics, Inc. Common Stock position peaked at $13K in Q1 2022.
- 7 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2022.
Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.